Elimination of second-hand smoke (SHS) exposure after a lung or head and neck (HN) cancer diagnosis and subsequent patient smoking cessation.

Authors

Lawson Eng

Lawson Eng

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Lawson Eng , Devon Alton , Yuyao Song , Delaram Farzanfar , Olivia Krys , Tom Yoannidis , Robin Milne , Steven Habbous , M Catherine Brown , Ashlee Vennettilli , Frances A. Shepherd , Natasha B. Leighl , Andrew J. Hope , Doris Howell , Jennifer M. Jones , Peter Selby , Wei Xu , David Paul Goldstein , Meredith Elana Giuliani , Geoffrey Liu

Organizations

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Princess Margaret Cancer Centre, Toronto, ON, Canada, Ontario Cancer Institute, Toronto, ON, Canada, Wharton Head and Neck Program, Princess Margaret Cancer Centre, Toronto, ON, Canada, Princess Margaret Cancer Centre, University Health Network, Ontario Cancer Institute, Toronto, ON, Canada, Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada, Centre for Addiction and Mental Health, Toronto, ON, Canada, Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada, Princess Margaret Cancer Center, Toronto, ON, Canada, Princess Margaret Hospital, Toronto, ON, Canada

Research Funding

No funding sources reported

Background: Exposure to SHS after a cancer diagnosis is associated with continued smoking in lung and HN cancer patients (PMID: 24419133, 23765604). However, smoking is a social activity. We evaluated whether elimination of SHS exposure around and after a diagnosis of lung or HN cancer is associated with smoking cessation in the cancer patient. Methods: Lung and HN cancer patients from Princess Margaret Cancer Centre (2006-12) completed questionnaires at diagnosis and follow-up (median 2 years apart) that assessed smoking history and SHS exposures (cohort study). Multivariate logistic regression analysis evaluated the association of elimination of SHS exposure after a diagnosis of cancer with subsequent smoking cessation, adjusted for significant covariates. A cross-sectional study (2014-15) of 183 lung and HN smoking patients assessed consistency in associations and interest in SHS cessation programs. Results: For the cohort study, 261/731 lung and 145/450 HN cancer patients smoked at diagnosis; subsequent quit rates were 69% and 50% respectively. 91% of lung and 94% of HN cancer patients were exposed to SHS at diagnosis while only 40% (lung) and 62% (HN) were exposed at follow-up. Elimination of SHS exposure was associated with smoking cessation in lung (aOR = 4.76, 95% CI [2.56-9.09], P< 0.001), HN (aOR = 5.00 [1.61-14.29], P< 0.001), and combined cancers (aOR = 5.00 [3.03-8.33], P< 0.001). The cross-sectional study has similar cessation and SHS exposure rates and a similar association for elimination of SHS with smoking cessation (aOR = 3.42 [1.16-10.10], P= 0.03). However when asked directly, only 26% of patients quit smoking with another individual and 13% of patients exposed to SHS had at least 1 interested party in joining a SHS cessation program. Conclusions: Elimination of SHS exposure around patients is significantly associated with smoking cessation in lung and HN cancer patients, but few patients quit smoking together with others around them, despite the ‘teachable moment’ with a cancer diagnosis. Clinicians should encourage patients and their household/friends to quit smoking together to improve cessation rates in cancer patients and those around them.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 Cancer Survivorship Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Care Coordination and Financial Implications,Communication,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Recurrence and Secondary Malignancies

Sub Track

Smoking Cessation

Citation

J Clin Oncol 34, 2016 (suppl 3S; abstr 183)

DOI

10.1200/jco.2016.34.3_suppl.183

Abstract #

183

Poster Bd #

P3

Abstract Disclosures

Similar Abstracts

First Author: Lawson Eng

First Author: Geoffrey Liu

Abstract

2019 ASCO Annual Meeting

Impact of smoking cessation in locally advanced head and neck cancers undergoing radiation.

First Author: Ruth Lauren Sacks

First Author: Jamie S. Ostroff